Metraipolis › archive › dc_c272295dee87

Repurposed agents in the Alzheimer's disease drug development pipeline — Europe PMC PMID:32807237

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/32807237
DOI
10.1186/s13195-[numero omesso]-x
License (as archived)
solo-consultazione
Archived
2026-10-07T12:21:01.759Z
SHA-256 of the archived text
23a0e1cd67811aad9db5446b14af1b04da089ec3dbca189f5b031c0b55d9dd58
Stable URL of this page
https://metraipolis.com/documento/dc_c272295dee87

How to cite

Repurposed agents in the Alzheimer's disease drug development pipeline — Europe PMC PMID:32807237 — Europe PMC (en), https://europepmc.org/article/MED/32807237 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_c272295dee87 (Metraipolis archive dc_c272295dee87, sha256 23a0e1cd67811aad9db5446b14af1b04da089ec3dbca189f5b031c0b55d9dd58)
BibTeX
@misc{dcc272295dee87,
  title = {Repurposed agents in the Alzheimer's disease drug development pipeline — Europe PMC PMID:32807237},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/32807237},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_c272295dee87; sha256 23a0e1cd67811aad9db5446b14af1b04da089ec3dbca189f5b031c0b55d9dd58},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/32807237. Agents can read the archived copy with the MCP tool read_document.